Skip to main content

and
  1. No Access

    Article

    Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach

    Obesity and opioid use for chronic pain in obese individuals are both important public health concerns. The pharmacokinetics of oral morphine after Roux-en-Y gastric bypass (RYGB) are unknown. Therefore, we ai...

    Célia Lloret-Linares, Déborah Hirt, Christophe Bardin in Clinical Pharmacokinetics (2014)

  2. No Access

    Article

    Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion

    Patients with acquired immunodeficiency syndrome (AIDS) have an increased risk of malignancies such as Kaposi’s sarcoma, primary central nervous system lymphoma, non-Hodgkin’s lymphoma, and cervical cancer, bu...

    Célia Lloret Linares, Didier Troisvallets, Pierre Sellier in Medical Oncology (2010)

  3. No Access

    Article

    Pharmacology of Morphine in Obese Patients

    Morphine is an analgesic drug used to treat acute and chronic pain. Obesity is frequently associated with pain of various origins (e.g. arthritis, fibromyalgia, cancer), which increases the need for analgesic ...

    Célia Lloret Linares, Xavier Decléves, Jean Michel Oppert in Clinical Pharmacokinetics (2009)